Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Adhera Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - Adhera Therapeutics, Inc. | t1401389_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Adhera Therapeutics, Inc. | t1401389_ex32-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Adhera Therapeutics, Inc. | t1401389_ex21-1.htm |
| 10-K - FORM 10-K - Adhera Therapeutics, Inc. | t1401389_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Nos. 333-46214, 333-49514, 333-92222, 333-118206, 333-126905, 333-135724, 333-146183, 333-153594, 333-170071, and 333-175793) on Form S-8 of Marina Biotech, Inc. of our report dated August 4, 2014 with respect to the consolidated financial statements, which appear in this Annual Report on Form 10-K of Marina Biotech, Inc. for the year ended December 31, 2013.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
August 4, 2014